Our partnership with SchrÖdinger
We have a longstanding, exclusive partnership with Schrödinger, the leader in chemical simulation and in silico drug discovery. Schrödinger developers work alongside Nimbus medicinal chemists and biologists to write bespoke code and develop new in silico algorithms to overcome challenges specific to Nimbus programs. Our joint team designs, iterates and optimizes leads using a variety of next-generation, physics-based technologies, enabling the rapid iteration and refinement of new methodologies. Nowhere else in the industry does there exist such a tight integration between in silico tools and classic drug discovery expertise.